Tang Capital Management LLC Lian Bio Transaction History

Tang Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.33 - $4.6 $11.2 Million - $38.7 Million	8,404,761 Added 873.66%	9,366,783 $41.9 Million
Q2 2023 Aug 14, 2023	BUY	$1.79 - $2.85 $1.35 Million - $2.14 Million	752,422 Added 358.98%	962,022 $2.19 Million
Q1 2023 May 15, 2023	BUY	$1.57 - $2.66 $235,500 - $399,000	150,000 Added 251.68%	209,600 $410,000
Q4 2022 Feb 14, 2023	BUY	$1.14 - $2.11 $67,944 - $125,755	59,600 New	59,600 $97,000

1.09M

Ticker LIAN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 108,354,000
Market Cap $32.5M
Description
LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, respiratory, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with p...

Get notified when there are updates to the investment portfolio of Tang Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tang Capital Management LLC with notifications on news.